UCLA Hematology Oncology — Irvine, California

UCLA Hematology Oncology is a clinical research site located in Irvine, California, United States 92604.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Hematology Oncology has participated in 3 clinical trials.

Therapeutic areas: Metastatic Colorectal Carcinoma, Non Small Cell Lung Cancer (NSCLC), HER2+ Metastatic Breast Cancer (MBC).

Sponsors: Pfizer, Puma Biotechnology, Inc..

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology Oncology?

UCLA Hematology Oncology has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology Oncology conducted?

UCLA Hematology Oncology has 3 clinical trials on record. Their work covers Metastatic Colorectal Carcinoma, Non Small Cell Lung Cancer (NSCLC), HER2+ Metastatic Breast Cancer (MBC).

Is UCLA Hematology Oncology accredited by Crixeo Health?

UCLA Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.